News | January 18, 2009

Wrist Access Safer, Easier for Many Patients Undergoing PCI

January 19, 2009 – The radial access approach to minimally invasive procedures will mean less bleeding, less down time, lower costs and less risk overall, particularly for obese patients, according to data being presented at the 21st annual International Symposium on Endovascular Therapy (ISET) this week near Miami Beach, FL.

Every year, about 1 million Americans opt for angioplasty over bypass surgery to open their blocked arteries. New data suggests that beginning the angioplasty procedure by entering through the wrist - rather than through the groin - will make it safer and easier on patients.

There is a risk of bleeding and nerve damage at the femoral artery access site. To reduce the risk, patients must lie down for two to six hours after treatment. Also, accessing the femoral artery in the groin is particularly challenging and risky in obese people.

Accessing the blocked blood vessels through the wrist (radial) artery, rather than the femoral artery significantly reduces the risk of bleeding and nerve damage, suggests data on more than 5,000 procedures performed at Baptist Cardiac and Vascular Institute, Miami. The radial approach also is easier on patients because they can sit up after the procedure and walk away almost immediately.

Currently, only about 2 percent of all minimally invasive heart treatments are performed through the wrist.

“I believe 75 percent of patients would be candidates for the radial approach if it were an option,” said Ramon Quesada, M.D., medical director of interventional cardiology at Baptist Cardiac and Vascular Institute, and ISET course director. “The radial approach is a bit more technically challenging for physicians, but once they master it, I think most would prefer it. One of the main barriers is a lack of training opportunities.”

When the femoral access approach is used, there is a 2.8 percent risk of bleeding or nerve damage, according to studies. Most patients spend at least one night in the hospital after the procedure. Although rare, the bleeding can lead to kidney failure, blood infection and death. At Baptist Cardiac and Vascular Institute, the complication rates for the radial approach are extremely low; only 0.3 percent had bleeding complications. None suffered nerve damage. An overnight stay may be advisable, depending on the complexity of the intervention performed, not because of the access approach.

The radial approach is not appropriate for all patients, including those who have very small or twisted arteries or are extremely thin, said Dr. Quesada.

“Using the radial approach results in lower cost, less time before the patient can get up and walk around and fewer complications,” said Dr. Quesada. “Patients who are ideal candidates for the radial approach are those who are obese or have severe peripheral arterial disease (PAD).”

For more information: www.ISET.org


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now